Lemonade's shares experienced a considerable uplift today, following an optimistic reassessment from Morgan Stanley. This surge is largely attributed to the company's pioneering efforts in the autonomous vehicle insurance sector, especially its collaboration with Tesla. Analysts believe this strategic positioning offers Lemonade a unique advantage, potentially expanding its business tenfold and significantly enhancing its long-term financial prospects, despite its current premium valuation.
The positive shift in sentiment from Morgan Stanley was initiated by analyst Bob Huang, who elevated Lemonade's rating from 'Equal-Weight' to 'Overweight' and increased its price target to $85, suggesting a potential 47% upside from its current trading price of $57.74. This upgrade stems from Lemonade's innovative approach to insurance, particularly its offering of a 50% discount on auto insurance for Tesla owners with activated Full Self-Driving capabilities. This initiative not only attracts a specific demographic of technologically-forward drivers but also establishes Lemonade as a frontrunner in underwriting risks associated with self-driving technology.
Morgan Stanley's bullish outlook is firmly rooted in the expectation that Lemonade will expand its presence in autonomous insurance as self-driving technologies become more widespread and adopted by various automakers. The firm projects that this segment alone could lead to a tenfold increase in Lemonade's business volume, with 'Lemonade Car' being the primary driver of this growth. This strategic focus is seen as a crucial element in improving Lemonade's earnings power over the long run.
From a technical analysis perspective, Lemonade's stock is currently trading 21% above its 20-day Simple Moving Average (SMA), indicating a strong short-term rebound. Although it remains 5.1% below its 100-day SMA, suggesting a need for sustained momentum to fully recover its intermediate trend, the stock has appreciated by 81.73% over the past year and is nearing its 52-week highs. The Relative Strength Index (RSI) at 46.70 signals neutral territory, implying that the recent rally is not yet overextended. Furthermore, the Moving Average Convergence Divergence (MACD) at -4.1011, compared to a signal line of -5.2468, maintains a bullish momentum setup, even with the MACD level below zero, pointing towards a lean towards bullish momentum. Key resistance is identified at $75.00, with support at $64.00.
The consensus among analysts generally assigns a 'Hold' rating to Lemonade, with an average price target of $46.28. However, recent analyst actions show a divergence, with Morgan Stanley's upgrade to 'Overweight' and an $85 target, alongside a 'Keefe, Bruyette & Woods' rating of 'Underperform' with a $44 target, and 'Cantor Fitzgerald' maintaining an 'Overweight' rating with a $92 target. Benzinga Edge's scorecard emphasizes the stock's strong momentum, indicating it outperforms the broader market in this aspect. For Lemonade to sustain its upward trajectory, holding above the mid-$60s and pushing towards $75 is critical; otherwise, the $64 support level could once again come into play. As of Tuesday's publication, Lemonade shares witnessed a 15.64% increase, trading at $66.77.
